A man with pityriasis rubra pilaris (PRP) showed no improvement in skin symptoms despite treatment with several drugs. The patient was diagnosed as having type 1 PRP. Combination therapy with cyclosporine and guselkumab improved his skin condition. Here, we propose a novel therapeutic strategy for intractable PRP.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540577 | PMC |
http://dx.doi.org/10.1002/ccr3.6413 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!